CRVS: Corvus Pharmaceuticals, Inc. Stock

by  •  • Comments Off on CRVS: Corvus Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 321.93
Enterprise Value ($M) 317.25
Book Value ($M) 12.41
Book Value / Share 0.19
Price / Book 25.94
NCAV ($M) -3.48
NCAV / Share -0.05
Price / NCAV -92.38

Profitability (mra)
Return on Invested Capital (ROIC) -4.22
Return on Assets (ROA) -1.25
Return on Equity (ROE) -1.47

Liquidity (mrq)
Quick Ratio 0.92
Current Ratio 0.92

Balance Sheet (mrq) ($M)
Current Assets 42.92
Assets 58.81
Liabilities 46.41
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
08-01 13G/A Samlyn Capital, Llc 9.99 -0.07
05-09 13G Point72 Asset Management, L.P. 9.90
05-08 13D/A Orbimed Advisors Llc 11.10 0.00
02-13 13G/A Miller Richard A Md 7.19 18.64

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-21 41,666 297,037 14.03
2025-01-17 180,739 669,679 26.99
2025-01-16 206,334 802,767 25.70

(click for more detail)

Similar Companies
CRMD – CorMedix Inc. CRON – Cronos Group Inc.
CRSP – CRISPR Therapeutics AG CURR – CURRENC Group Inc.
CVAC – CureVac N.V.


Financial data and stock pages provided by
Fintel.io